We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Signaling Molecules Found that Direct Axon Growth

By Biotechdaily staff writers
Posted on 02 Apr 2003
A study has found that during brain development in Drosophila, the direction in which nerve cells grow, called commissure choice, is controlled by Derailed, an atypical receptor tyrosine kinase expressed on axons projecting in the anterior commissure. More...
The study was published March 16, 2003, in the online edition of Nature.

Investigators from the Salk Institute (La Jolla, CA, USA) found that a protein called Wnt5, a member of a large family of signaling molecules, became bound to a receptor called Derailed that is present on the surface of growing nerve cells.

In nervous systems with bilateral symmetry, many neurons project axons across the midline to the opposite side. The current study revealed an unexpected role in axon guidance for a Wnt family member and showed that the Derailed receptor is an essential component of Wnt signalling in these guidance events.




Related Links:
The Salk Institute

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.